Efaproxiral (RSR13) - Moligand™,10mM in DMSO , Hemoglobin HbA negative modulator, CAS No.131179-95-8, Hemoglobin HbA negative modulator

CAS: 131179-95-8 Cat. No.: E656594 Summenformel: C20H23NO4 Molekulargewicht: 341.40
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1ml
E656594-1ml
Auf Bestellung · 8–12 Wochen
60,65€
Enter a quantity for the sizes you want to add.

Übersicht

Efaproxiral is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy

In Vitro

Efaproxiral binds to only one pair of symmetry-related sites in the Hb central water cavity. Efaproxiral readily crosses the red cell membrane in the presence of serum albumin solutions. Efaproxiral is not inhibited from entering erythrocytes in the presence of an anion-channel blocking agent (DIDS). MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Efaproxiral (150 mg/kg, i.p.) increase tumor oxygenation,and increase the tumor growth inhibition of radiotherapy over 5 days of treatment. Efaproxiral reduces hemoglobin-oxygen binding affinity, which facilitates oxygen release from hemoglobin into surrounding tissues and potentially increases the pO(2) of the tumorsMCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female C3H/HEJ mice (18–20 g), with radiation-induced fibrosarcoma tumor (RIF-1) cells xenograftDosage: 150 mg/kg Administration: Intraperitoneal injection; prior to X Irradiation (4 Gy/day), for 5 days Result: Significantly increased tumor oxygenation by 8.4 to 43.4 mmHg within 5 days, with maximum increases at 22–31 minutes after treatment.

IC50& Target:haemoglobin (Hb)

Spezifikationen

Spezifikationen & Reinheit
Moligand™,10mM in DMSO
Biochemische und physiologische Mechanismen
Efaproxiral is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy.
Storage
Store at -80°C
Verschickt in
Dry ice packs + Cold packs
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
NEGATIVE MODULATOR
Mechanismus der Wirkung
Hemoglobin HbA negative modulator
Produkteigenschaften
ALogP
3.6
Namen und Kennungen
Isomere SMILES
CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)O)C
Molekulargewicht
341.40

Erweiterte Daten

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Häufig gestellte Fragen

What are the CAS number, molecular formula and molecular weight?
The CAS Number is 131179-95-8, the molecular formula is C20H23NO4, and the molecular weight is 341.40 g/mol.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.